FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975343712> ?p ?o ?g. }

• W1975343712 endingPage "221" @default.
• W1975343712 startingPage "211" @default.
• W1975343712 abstract "Review the association between attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD) in children and adolescents. Discuss treatment implications and the role of the primary care physician in the management of this comorbidity.Articles published from 1991 to 2007 were identified through a MEDLINE search using the search terms attention-deficit/hyperactivity disorder and substance use disorder.Publications cited include reviews of substance use disorders in children and adolescents with ADHD, manuals of diagnostic tests, and 69 studies of substance use disorders in children and adolescents with ADHD. No non-English-language publications were identified.Recent reports identify SUD in a high proportion of respondents with ADHD and ADHD in a high proportion of respondents with many types of SUD. Factors that appear to increase the risk for SUD include comorbid psychiatric disorders, particularly conduct disorder. Pharmacotherapy for ADHD appears not to increase the risk for subsequent SUD. Guidelines for the evaluation and treatment of patients with comorbid ADHD and SUD are outlined. Psycho-stimulants carry the risk for misuse by both patients and family members through diversion. Although nonstimulants such as atomoxetine have low abuse potential, they appear to be less efficacious than stimulants. Formulations that have the potential to lower the abuse liability of stimulants are being developed. These include a transdermal form of methylphenidate that has been shown to be efficacious in the treatment of ADHD and a prodrug stimulant, lisdexamfetamine, recently approved for the treatment of ADHD. Clinical data indicate that lisdexamfetamine is efficacious, and significantly lower likability scores were seen with lisdexamfetamine than with equivalent oral doses of d-amphetamine sulfate.Pharmacotherapy may reduce the risk for SUD in patients with ADHD. Psycho-stimulants remain the first-line therapy for the core symptoms of ADHD. New formulations of pharmacologic agents with a reduced potential for abuse are being developed." @default.
• W1975343712 created "2016-06-24" @default.
• W1975343712 creator A5081140079 @default.
• W1975343712 date "2008-06-16" @default.
• W1975343712 modified "2023-10-16" @default.
• W1975343712 title "Substance Use Disorders in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder" @default.
• W1975343712 cites W1232286304 @default.
• W1975343712 cites W134915759 @default.
• W1975343712 cites W1532202563 @default.
• W1975343712 cites W166008495 @default.
• W1975343712 cites W1783740760 @default.
• W1975343712 cites W190428261 @default.
• W1975343712 cites W1913907396 @default.
• W1975343712 cites W1965719747 @default.
• W1975343712 cites W1965931696 @default.
• W1975343712 cites W1966811160 @default.
• W1975343712 cites W1967128208 @default.
• W1975343712 cites W1973135962 @default.
• W1975343712 cites W1976799195 @default.
• W1975343712 cites W1980101531 @default.
• W1975343712 cites W1980400438 @default.
• W1975343712 cites W1980610274 @default.
• W1975343712 cites W1992488678 @default.
• W1975343712 cites W1995084008 @default.
• W1975343712 cites W1995973822 @default.
• W1975343712 cites W1998889977 @default.
• W1975343712 cites W2004720330 @default.
• W1975343712 cites W2006553027 @default.
• W1975343712 cites W2008181018 @default.
• W1975343712 cites W2008412558 @default.
• W1975343712 cites W2014051345 @default.
• W1975343712 cites W2016483680 @default.
• W1975343712 cites W2018897037 @default.
• W1975343712 cites W2020973197 @default.
• W1975343712 cites W2021236447 @default.
• W1975343712 cites W2025137648 @default.
• W1975343712 cites W2026188485 @default.
• W1975343712 cites W2026557844 @default.
• W1975343712 cites W2028877810 @default.
• W1975343712 cites W2032763172 @default.
• W1975343712 cites W2033304004 @default.
• W1975343712 cites W2037097415 @default.
• W1975343712 cites W2040513075 @default.
• W1975343712 cites W2041057759 @default.
• W1975343712 cites W2045075022 @default.
• W1975343712 cites W2047530246 @default.
• W1975343712 cites W2051022393 @default.
• W1975343712 cites W2051917621 @default.
• W1975343712 cites W2054753933 @default.
• W1975343712 cites W2055010632 @default.
• W1975343712 cites W2055878958 @default.
• W1975343712 cites W2056434954 @default.
• W1975343712 cites W2056663519 @default.
• W1975343712 cites W2056794942 @default.
• W1975343712 cites W2058530403 @default.
• W1975343712 cites W2062970041 @default.
• W1975343712 cites W2068742057 @default.
• W1975343712 cites W2078373986 @default.
• W1975343712 cites W2079590493 @default.
• W1975343712 cites W2080074611 @default.
• W1975343712 cites W2083015785 @default.
• W1975343712 cites W2083625158 @default.
• W1975343712 cites W2087174543 @default.
• W1975343712 cites W2093587140 @default.
• W1975343712 cites W2098954626 @default.
• W1975343712 cites W2105519641 @default.
• W1975343712 cites W2106829915 @default.
• W1975343712 cites W2109413549 @default.
• W1975343712 cites W2112484680 @default.
• W1975343712 cites W2114290463 @default.
• W1975343712 cites W2118007717 @default.
• W1975343712 cites W2121127876 @default.
• W1975343712 cites W2125895516 @default.
• W1975343712 cites W2128797729 @default.
• W1975343712 cites W2129620184 @default.
• W1975343712 cites W2131627337 @default.
• W1975343712 cites W2134360118 @default.
• W1975343712 cites W2145440976 @default.
• W1975343712 cites W2145746293 @default.
• W1975343712 cites W2147653143 @default.
• W1975343712 cites W2153514014 @default.
• W1975343712 cites W2157140914 @default.
• W1975343712 cites W2159310202 @default.
• W1975343712 cites W2166577179 @default.
• W1975343712 cites W2167062019 @default.
• W1975343712 cites W2167367466 @default.
• W1975343712 cites W2285134444 @default.
• W1975343712 cites W2291922539 @default.
• W1975343712 cites W2327840235 @default.
• W1975343712 cites W2888094372 @default.
• W1975343712 cites W367527110 @default.
• W1975343712 cites W629283852 @default.
• W1975343712 cites W72468019 @default.
• W1975343712 cites W2119535138 @default.
• W1975343712 doi "https://doi.org/10.4088/pcc.v10n0306" @default.
• W1975343712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2446489" @default.
• W1975343712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18615170" @default.
• W1975343712 hasPublicationYear "2008" @default.

• next